Krystal Biotech Hits Day High with 8.37% Surge in Stock Price

Krystal Biotech, Inc. has experienced a significant surge in its stock performance, gaining 8.37% on September 15, 2025. The stock reached an intraday high of USD 156.25, reflecting strong market activity. Over the past day, Krystal Biotech's performance outpaced the S&P 500, which saw a slight decline of 0.05%.
In the past week, the stock has risen by 18.94%, and over the past month, it has increased by 17.8%. However, its year-to-date performance shows a modest decline of 0.61%, contrasting with the S&P 500's gain of 11.95%. Notably, Krystal Biotech has demonstrated impressive long-term growth, with a remarkable 178.65% increase over three years and a substantial 225.89% rise over five years.

The company has reported a net profit growth of 146.23% and has posted positive results for the last seven consecutive quarters. With a market capitalization of USD 4,203 million, Krystal Biotech operates within the pharmaceuticals and biotechnology sector, showcasing strong financial metrics such as a return on equity of 15.20% and a high institutional holding rate of 100%.